| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
12,983 |
11,565 |
$1.27M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,767 |
3,528 |
$299K |
| 99215 |
Prolong outpt/office vis |
940 |
876 |
$137K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
276 |
271 |
$50K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
175 |
174 |
$22K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,131 |
551 |
$21K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
535 |
481 |
$20K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
500 |
487 |
$17K |
| 80305 |
|
965 |
844 |
$11K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
591 |
519 |
$10K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
438 |
431 |
$8K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
178 |
164 |
$4K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
70 |
66 |
$4K |
| 99072 |
|
33 |
33 |
$2K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
14 |
14 |
$2K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
14 |
14 |
$2K |
| 96127 |
|
140 |
138 |
$1K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
17 |
17 |
$1K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
47 |
46 |
$1K |
| 81002 |
|
264 |
252 |
$965.01 |
| 93000 |
|
13 |
13 |
$213.28 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
12 |
12 |
$124.75 |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
13 |
13 |
$39.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
15 |
12 |
$35.39 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
26 |
26 |
$12.19 |
| 1160F |
|
970 |
849 |
$0.00 |
| 3078F |
|
742 |
661 |
$0.00 |
| 1159F |
|
971 |
851 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
91 |
83 |
$0.00 |
| 3077F |
|
214 |
195 |
$0.00 |
| G8783 |
Normal blood pressure reading documented, follow-up not required |
38 |
35 |
$0.00 |
| 3075F |
|
150 |
147 |
$0.00 |
| 3079F |
|
271 |
265 |
$0.00 |
| 1170F |
|
435 |
366 |
$0.00 |
| 4010F |
|
301 |
252 |
$0.00 |
| 3074F |
|
869 |
778 |
$0.00 |
| 4050F |
|
181 |
161 |
$0.00 |
| 3080F |
|
187 |
175 |
$0.00 |
| 3044F |
|
15 |
15 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
43 |
39 |
$0.00 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
16 |
15 |
$0.00 |